EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Molecular Design and Anticancer Activities of Small‐Molecule BRAF Inhibitors: A Medicinal Chemistry Perspective

Shuyu Jia, Jieman Lin, Janjun Wu, Hao Xu, Qingwei Zeng, Meipin Liu, Jiayi Shen iD

Drug Development Research · 2026-11 · 87 (7)

DOI: 10.1002/ddr.70389 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Development Research, online erschienen am 22.09.2026. Verfasst von Shuyu Jia und 6 weiteren Autor:innen. Beteiligte Einrichtung: Jiangxi Provincial Key Laboratory of Synthetic Pharmaceutical Chemistry, Gannan Normal University, Ganzhou, China. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins B-raf, Protein Kinase Inhibitors, Antineoplastic Agents, Drug Design. Die Arbeit nennt 146 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Jiangxi Provincial Natural Science Foundation, Doctor Foundation of Gannan Normal University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BRAF is a cytoplasmic serine‐threonine protein kinase that plays a critical role in the MAPK signaling pathway. BRAF is the only member of the RAF family activated by mutation in human cancers. Many classes of B‐Raf small molecule inhibitors have been identified. In this review, we will highlight typical BRAF inhibitors developed during these decades and provide a reference for the exploration of more potential BRAF inhibitors in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins B-rafProtein Kinase InhibitorsAntineoplastic AgentsDrug DesignNeoplasmsHumansChemistry, PharmaceuticalStructure-Activity RelationshipAnimals

Stichwörter der Autor:innen

BRAF inhibitorscancerdrug design structure activity relationship

Substanzen

Proto-Oncogene Proteins B-rafProtein Kinase InhibitorsAntineoplastic AgentsBRAF protein, human

Autor:innen und Institutionen

  • Jiangxi Provincial Key Laboratory of Synthetic Pharmaceutical Chemistry, Gannan Normal University, Ganzhou, China.
  • Jiangxi Drug Inspection Center, Ganzhou, China.

ORCID-Profile: Jiayi Shen

Förderung

  • National Natural Science Foundation of China
  • Jiangxi Provincial Natural Science Foundation
  • Doctor Foundation of Gannan Normal University

Zitieren

APA

Jia, S., Lin, J., Wu, J., Xu, H., Zeng, Q., Liu, M., & Shen, J. (2026). Molecular Design and Anticancer Activities of Small‐Molecule BRAF Inhibitors: A Medicinal Chemistry Perspective. Drug Development Research, 87(7). https://doi.org/10.1002/ddr.70389

Vancouver

Jia S, Lin J, Wu J, Xu H, Zeng Q, Liu M, et al. Molecular Design and Anticancer Activities of Small‐Molecule BRAF Inhibitors: A Medicinal Chemistry Perspective. Drug Development Research. 2026;87(7). doi:10.1002/ddr.70389

BibTeX
@article{Jia2026,
  author = {Jia, Shuyu and Lin, Jieman and Wu, Janjun and Xu, Hao and Zeng, Qingwei and Liu, Meipin and Shen, Jiayi},
  title = {Molecular Design and Anticancer Activities of Small‐Molecule BRAF Inhibitors: A Medicinal Chemistry Perspective},
  journal = {Drug Development Research},
  year = {2026},
  volume = {87},
  number = {7},
  doi = {10.1002/ddr.70389}
}
Kostenlos starten →